Table 5 Characteristics and prognosis of patients
Patients age/sex | Tumor thrombus | Residual tumor | Metastatic recurrence | Outcome (cause of death) | ||
|---|---|---|---|---|---|---|
Hepatic | Distant | Hepatic | Distant | |||
68/M | RA | (−) | (−) | (+) | (+) (lung, Ad) | 30.8 months; dead (cancer) |
57/M | IVC | (−) | (−) | (+) | (−) | 10.1 months; dead (cancer) |
70/M | RA | (+) | (−) |  | (+) (lung) | 9.1 months; dead (cancer) |
86/F | IVC | (−) | (−) | (+) | (+) (lung, IVC) | 15.3 months; dead (cancer) |
68/M | IVC | (−) | (−) | (+) | (+) (lung, LN) | 51.8 months; alive |
66/M | RA | (−) | (+) (lung) | (+) | (+) (LN) | 11.2 months; dead (cancer) |
37/M | IVC | (−) | (+) (lung) | (−) | (+) (Ad, LN, Brain) | 10.5 months; dead (cancer) |
56/M | IVC | (−) | (+) (lung) | (−) | (−) | 29.3 months; alive |
51/M | RA | (−) | (+) (lung) | (+) | (+) (Brain) | 8.5 months; dead (cancer) |
72/M | IVC | (+) | (+) (lung) | Â | (+) (LN) | 1.9 months; dead (cancer) |
59/M | RA | (−) | (−) | (+) | (+) (lung) | 16.5 months; alive |
69/M | IVC | (−) | (+) (LN) | (+) | (+) (lung, IVC) | 16.0 months; alive |
65/M | RA | (+) | (−) |  | (+) (lung) | 7.6 months; alive |